Integrated DNA Technologies at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

Integrated DNA Technologies brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 1014. Its session covers automated workflows for profiling hematologic malignancies in cancer research and emerging hybrid capture applications. The company manufactures custom oligonucleotides for genomics laboratories.

OrganizationAMP 2026 Attendance
Suppliers
Manufactures custom oligonucleotides for genomics laboratories, with synthesis, modification, purification and quality control capabilities.
Booth
Exhibiting at Booth 1014
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
11:00am–11:50am
Enabling Scalable Molecular Profiling in Cancer Research: Automated Hematologic Malignancy Workflows and Emerging Hybrid Capture Applications
Automated library preparation for blood cancer research panels, plus hybrid capture uses spanning methylation and cytomegalovirus assays.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Integrated DNA Technologies

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction